Stem cell therapy for severe low blood sugar in diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have long-standing type 1 diabetes or diabetes from pancreas problems.
- You have had at least one severe low blood sugar event in the past year that needed help from someone else.
- You are able to check your blood sugar often and use a special monitoring device provided by the study.
- You do not have type 2 diabetes, a BMI over 30, or serious health issues like heart disease or active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.
This trial tests whether giving your own regulatory T cells (a type of immune cell) back to you can help slow or stop the immune attack on your pancreas in type 1 diabetes. It is for people aged 8 to 65 who still make some insulin.
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
This trial tests a new treatment using pancreatic cells that may help people with type 1 diabetes make insulin again. It aims to reduce severe low blood sugar episodes and improve blood sugar control.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Hear when a new Pancreatogenic Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.